LIFEMD INC (LFMD) Stock Fundamental Analysis
NASDAQ:LFMD - US53216B1044 - Common Stock
6.08 USD
-0.02 (-0.33%)
6.06 USD
-0.02 (-0.33%)
We assign a fundamental rating of 3 out of 10 to LFMD. LFMD was compared to 35 industry peers in the Health Care Technology industry. LFMD may be in some trouble as it scores bad on both profitability and health. LFMD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year LFMD has reported negative net income.
LFMD had a positive operating cash flow in the past year.
In the past 5 years LFMD always reported negative net income.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
LFMD has a Return On Assets (-12.28%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMD has a Gross Margin of 87.57%. This is amongst the best in the industry. LFMD outperforms 94.29% of its industry peers.
LFMD's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LFMD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
LFMD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LFMD has been reduced compared to a year ago.
2.2 Solvency
LFMD has an Altman-Z score of 0.66. This is a bad value and indicates that LFMD is not financially healthy and even has some risk of bankruptcy.
LFMD's Altman-Z score of 0.66 is in line compared to the rest of the industry. LFMD outperforms 51.43% of its industry peers.
LFMD has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMD would need 2.31 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.31, LFMD is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | 0.66 |
ROIC/WACCN/A
WACC10.12%
2.3 Liquidity
A Current Ratio of 0.77 indicates that LFMD may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, LFMD is doing worse than 77.14% of the companies in the same industry.
LFMD has a Quick Ratio of 0.77. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMD has a Quick ratio of 0.72. This is in the lower half of the industry: LFMD underperforms 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.00%, which is quite impressive.
LFMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.74%.
LFMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.23% yearly.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
3.2 Future
The Earnings Per Share is expected to grow by 42.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, LFMD will show a quite strong growth in Revenue. The Revenue will grow by 19.29% on average per year.
EPS Next Y86.4%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
EPS Next 5YN/A
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
LFMD is valuated rather expensively with a Price/Forward Earnings ratio of 23.10.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LFMD indicates a somewhat cheap valuation: LFMD is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.59, LFMD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 23.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFMD indicates a somewhat cheap valuation: LFMD is cheaper than 68.57% of the companies listed in the same industry.
LFMD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.87 | ||
| EV/EBITDA | 29.7 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMD's earnings are expected to grow with 42.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.71%
EPS Next 3Y42.4%
5. Dividend
5.1 Amount
No dividends for LFMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.08
-0.02 (-0.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners37.54%
Inst Owner Change41.96%
Ins Owners17.39%
Ins Owner Change5.14%
Market Cap273.84M
Analysts81.33
Price Target12.82 (110.86%)
Short Float %17.22%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)-10.2%
PT rev (3m)2.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-3363.64%
EPS NY rev (1m)-500%
EPS NY rev (3m)-176.92%
Revenue NQ rev (1m)-8.48%
Revenue NQ rev (3m)-5.72%
Revenue NY rev (1m)-6.39%
Revenue NY rev (3m)-6.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 23.1 | ||
| P/S | 1.12 | ||
| P/FCF | 40.87 | ||
| P/OCF | 14.06 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 29.7 |
EPS(TTM)-0.21
EYN/A
EPS(NY)0.26
Fwd EY4.33%
FCF(TTM)0.15
FCFY2.45%
OCF(TTM)0.43
OCFY7.11%
SpS5.45
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% | ||
| FCFM | 2.73% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 120.74% | ||
| Cap/Sales | 5.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 227.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 0.66 |
F-Score5
WACC10.12%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y86.4%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year279.84%
EBIT Next 3Y73.97%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%